The Casp1 expression pattern we found in our MDS patient cohort is in line with previously published flow cytometry-based results, where higher Casp1 expression was reported in mononuclear cells in lower- compared with higher-risk MDS patients [41]. The gene discussed is CASP1; the disease is myelodysplastic syndrome.